Robeco Institutional Asset Management’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,223
| Closed | -$491K | – | 924 |
|
|
2025
Q1 | $491K | Buy |
18,223
+3,887
| +27% | +$123K | ﹤0.01% | 835 |
|
|
2024
Q4 | $515K | Sell |
14,336
-5,492
| -28% | -$205K | ﹤0.01% | 830 |
|
|
2024
Q3 | $752K | Sell |
19,828
-3,929
| -17% | -$161K | ﹤0.01% | 804 |
|
|
2024
Q2 | $1.07M | Hold |
23,757
| – | – | ﹤0.01% | 763 |
|
|
2024
Q1 | $1.15M | Sell |
23,757
-62
| -0.3% | -$3.04K | ﹤0.01% | 759 |
|
|
2023
Q4 | $1.28M | Hold |
23,819
| – | – | ﹤0.01% | 758 |
|
|
2023
Q3 | $1.4M | Buy |
23,819
+5,064
| +27% | +$317K | ﹤0.01% | 742 |
|
|
2023
Q2 | $1.18M | Sell |
18,755
-732
| -4% | -$46.6K | ﹤0.01% | 764 |
|
|
2023
Q1 | $1.23M | Hold |
19,487
| – | – | ﹤0.01% | 749 |
|
|
2022
Q4 | $1.04M | Sell |
19,487
-3,182
| -14% | -$172K | ﹤0.01% | 774 |
|
|
2022
Q3 | $1.27M | Sell |
22,669
-680
| -3% | -$45K | ﹤0.01% | 678 |
|
|
2022
Q2 | $1.69M | Sell |
23,349
-2,180
| -9% | -$162K | 0.01% | 649 |
|
|
2022
Q1 | $2.03M | Buy |
25,529
+2,474
| +11% | +$223K | ﹤0.01% | 639 |
|
|
2021
Q4 | $2.33M | Hold |
23,055
| – | – | 0.01% | 628 |
|
|
2021
Q3 | $2.13M | Sell |
23,055
-18,246
| -44% | -$1.76M | ﹤0.01% | 653 |
|
|
2021
Q2 | $4.23M | Sell |
41,301
-4,322
| -9% | -$434K | 0.01% | 601 |
|
|
2021
Q1 | $4.45M | Sell |
45,623
-5,981
| -12% | -$544K | 0.01% | 574 |
|
|
2020
Q4 | $3.98M | Sell |
51,604
-9,098
| -15% | -$704K | 0.01% | 582 |
|
|
2020
Q3 | $4.47M | Sell |
60,702
-10,398
| -15% | -$834K | 0.01% | 530 |
|
|
2020
Q2 | $5.22M | Sell |
71,100
-16,789
| -19% | -$1.32M | 0.02% | 527 |
|
|
2020
Q1 | $5.08M | Buy |
87,889
+14,047
| +19% | +$977K | 0.02% | 539 |
|
|
2019
Q4 | $5.8M | Sell |
73,842
-35,118
| -32% | -$2.59M | 0.02% | 580 |
|
|
2019
Q3 | $7.45M | Sell |
108,960
-21,101
| -16% | -$1.42M | 0.03% | 525 |
|
|
2019
Q2 | $10.3M | Sell |
130,061
-116,355
| -47% | -$9.23M | 0.04% | 459 |
|
|
2019
Q1 | $20.7M | Buy |
246,416
+8,205
| +3% | +$856K | 0.08% | 337 |
|
|
2018
Q4 | $27.9M | Sell |
238,211
-2,800
| -1% | -$324K | 0.13% | 220 |
|
|
2018
Q3 | $29.1M | Buy |
241,011
+83,672
| +53% | +$10.4M | 0.12% | 234 |
|
|
2018
Q2 | $18.1M | Buy |
157,339
+135,778
| +630% | +$14.9M | 0.08% | 292 |
|
|
2018
Q1 | $1.85M | Buy |
21,561
+3,331
| +18% | +$258K | 0.01% | 674 |
|
|
2017
Q4 | $1.35M | Hold |
18,230
| – | – | 0.01% | 660 |
|
|
2017
Q3 | $1.05M | Hold |
18,230
| – | – | 0.01% | 650 |
|
|
2017
Q2 | $1.17M | Buy |
18,230
+14,308
| +365% | +$882K | 0.01% | 645 |
|
|
2017
Q1 | $226K | Hold |
3,922
| – | – | ﹤0.01% | 788 |
|
|
2016
Q4 | $240K | Hold |
3,922
| – | – | ﹤0.01% | 703 |
|
|
2016
Q3 | $271K | Buy |
+3,922
| New | +$259K | ﹤0.01% | 748 |
|
Other funds holding USNA
Robeco Institutional Asset Management's USNA Position: Q2 2025 in Review
Robeco Institutional Asset Management sold out of Usana Health Sciences (USNA) in Q2 2025, closing a stake of 18,223 shares — an estimated $491K sold.
Robeco Institutional Asset Management first reported a position in USNA in Q3 2016 and held it in 35 quarters. The position peaked at $29.1M in Q3 2018. 164 funds tracked by Wall St. Rank hold USNA as of Q2 2025.
- Robeco Institutional Asset Management reported no remaining Usana Health Sciences position as of Q2 2025 after selling out during the quarter.
- Robeco Institutional Asset Management sold 18,223 Usana Health Sciences shares in Q2 2025, an estimated $491K.
- Robeco Institutional Asset Management first reported a position in Usana Health Sciences in Q3 2016 and held it in 35 quarters.
- Robeco Institutional Asset Management's Usana Health Sciences position peaked at $29.1M in Q3 2018.
- 164 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2025.
Based on Robeco Institutional Asset Management's 13F filing for Q2 2025, filed 18 Jul 2025.